An Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy of Numorphan® CR (Oxymorphone HCL Controlled Release) in Subjects With Cancer Pain or Chronic Lower Back Pain.
收藏DataCite Commons2025-06-01 更新2024-07-13 收录
下载链接:
https://search.vivli.org/doiLanding/studies/PR00010213/isLanding
下载链接
链接失效反馈官方服务:
资源简介:
The purpose of this study is to evaluate the long-term safety and tolerability of oxymorphone
ER as an analgesic in cancer and lower back pain subjects having chronic moderate to severe
pain.
提供机构:
Vivli
创建时间:
2024-06-21



